This original ANADA submitted under section 512(b) of the Federal Food, Drug, and
Cosmetic Act satisfies the requirements of section 512(n) of the act and demonstrates that
SMZ-MED 454 Soluble Powder, when used under its proposed conditions of use, is safe and
effective for its labeled indications.
Read the full FDA statement and also the information about sulfamethazine possible side effects.
Read the full FDA statement and also the information about sulfamethazine possible side effects.
No comments:
Post a Comment